BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Falasca M, Kim M, Casari I. Pancreatic cancer: Current research and future directions. Biochim Biophys Acta. 2016;1865:123-132. [PMID: 26794394 DOI: 10.1016/j.bbcan.2016.01.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 49] [Article Influence: 7.2] [Reference Citation Analysis]
Number Citing Articles
1 Torres C, Grippo PJ. Pancreatic cancer subtypes: a roadmap for precision medicine. Ann Med 2018;50:277-87. [PMID: 29537309 DOI: 10.1080/07853890.2018.1453168] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
2 Haller SD, Monaco ML, Essani K. The Present Status of Immuno-Oncolytic Viruses in the Treatment of Pancreatic Cancer. Viruses. 2020;12. [PMID: 33213031 DOI: 10.3390/v12111318] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
3 Leppänen J, Helminen O, Huhta H, Kauppila JH, Isohookana J, Haapasaari KM, Lehenkari P, Saarnio J, Karttunen TJ. High toll-like receptor (TLR) 9 expression is associated with better prognosis in surgically treated pancreatic cancer patients. Virchows Arch 2017;470:401-10. [PMID: 28191612 DOI: 10.1007/s00428-017-2087-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
4 Markowski A, Migdał P, Zygmunt A, Zaremba-Czogalla M, Gubernator J. Evaluation of the In Vitro Cytotoxic Activity of Ursolic Acid PLGA Nanoparticles against Pancreatic Ductal Adenocarcinoma Cell Lines. Materials (Basel) 2021;14:4917. [PMID: 34501007 DOI: 10.3390/ma14174917] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Qin RF, Zhang J, Huo HR, Yuan ZJ, Xue JD. MiR-205 mediated APC regulation contributes to pancreatic cancer cell proliferation. World J Gastroenterol 2019; 25(28): 3775-3786 [PMID: 31391772 DOI: 10.3748/wjg.v25.i28.3775] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
6 Wang Y, Zhao R, Jiao X, Wu L, Wei Y, Shi F, Zhong J, Xiong L. Small Extracellular Vesicles: Functions and Potential Clinical Applications as Cancer Biomarkers. Life (Basel) 2021;11:1044. [PMID: 34685415 DOI: 10.3390/life11101044] [Reference Citation Analysis]
7 Laskowska AK, Puszko AK, Sosnowski P, Różycki K, Kosson P, Matalińska J, Durlik M, Misicka A. Opioid Tripeptides Hybridized with trans-1-Cinnamylpiperazine as Proliferation Inhibitors of Pancreatic Cancer Cells in Two- and Three-Dimensional in vitro Models. ChemMedChem 2017;12:1637-44. [PMID: 28834399 DOI: 10.1002/cmdc.201700453] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Mehta S, Tan GI, Nahm CB, Chua TC, Pearson A, Gill AJ, Samra JS, Mittal A. Pancreatic resection in patients with synchronous extra-pancreatic malignancy: outcomes and complications. ANZ J Surg 2020;90:290-4. [PMID: 31943690 DOI: 10.1111/ans.15651] [Reference Citation Analysis]
9 Tuerhong A, Xu J, Shi S, Tan Z, Meng Q, Hua J, Liu J, Zhang B, Wang W, Yu X, Liang C. Overcoming chemoresistance by targeting reprogrammed metabolism: the Achilles' heel of pancreatic ductal adenocarcinoma. Cell Mol Life Sci 2021;78:5505-26. [PMID: 34131808 DOI: 10.1007/s00018-021-03866-y] [Reference Citation Analysis]
10 Wang Y, Liu Z, Liu Q, Han Y, Zang Y, Zhang H, Du X, Qin T, Wu Y. Honokiol Suppressed Pancreatic Cancer Progression via miR-101/Mcl-1 Axis. Cancer Manag Res 2020;12:5243-54. [PMID: 32669873 DOI: 10.2147/CMAR.S237323] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Zhang L, Liu C, Gao H, Zhou C, Qin W, Wang J, Meng L, Wang H, Ren Q, Zhang Y. Study on the expression profile and role of decorin in the progression of pancreatic cancer. Aging (Albany NY) 2021;13:14989-98. [PMID: 34021540 DOI: 10.18632/aging.203060] [Reference Citation Analysis]
12 Waissi W, Paix A, Nicol A, Noël G, Burckel H. Targeting DNA repair in combination with radiotherapy in pancreatic cancer: A systematic review of preclinical studies. Crit Rev Oncol Hematol 2020;153:103060. [PMID: 32707435 DOI: 10.1016/j.critrevonc.2020.103060] [Reference Citation Analysis]
13 Yu L, Teoh ST, Ensink E, Ogrodzinski MP, Yang C, Vazquez AI, Lunt SY. Cysteine catabolism and the serine biosynthesis pathway support pyruvate production during pyruvate kinase knockdown in pancreatic cancer cells. Cancer Metab 2019;7:13. [PMID: 31893043 DOI: 10.1186/s40170-019-0205-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
14 Kunovsky L, Tesarikova P, Kala Z, Kroupa R, Kysela P, Dolina J, Trna J. The Use of Biomarkers in Early Diagnostics of Pancreatic Cancer. Can J Gastroenterol Hepatol 2018;2018:5389820. [PMID: 30186820 DOI: 10.1155/2018/5389820] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
15 Lane JS, Hoff DV, Cridebring D, Goel A. Extracellular Vesicles in Diagnosis and Treatment of Pancreatic Cancer: Current State and Future Perspectives. Cancers (Basel) 2020;12:E1530. [PMID: 32532129 DOI: 10.3390/cancers12061530] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
16 Du C, Chai NL, Linghu EQ, Li HK, Sun LH, Jiang L, Wang XD, Tang P, Yang J. Comparison of endoscopic ultrasound, computed tomography and magnetic resonance imaging in assessment of detailed structures of pancreatic cystic neoplasms. World J Gastroenterol 2017; 23(17): 3184-3192 [PMID: 28533675 DOI: 10.3748/wjg.v23.i17.3184] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
17 Miyoshi E, Kamada Y. Application of glycoscience to the early detection of pancreatic cancer. Cancer Sci 2016;107:1357-62. [PMID: 27418030 DOI: 10.1111/cas.13011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
18 Ferro R, Adamska A, Lattanzio R, Mavrommati I, Edling CE, Arifin SA, Fyffe CA, Sala G, Sacchetto L, Chiorino G, De Laurenzi V, Piantelli M, Sansom OJ, Maffucci T, Falasca M. GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine. Oncogene. 2018;37:6368-6382. [PMID: 30061636 DOI: 10.1038/s41388-018-0390-1] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 13.0] [Reference Citation Analysis]
19 Norouzi M, Amerian M, Amerian M, Atyabi F. Clinical applications of nanomedicine in cancer therapy. Drug Discovery Today 2020;25:107-25. [DOI: 10.1016/j.drudis.2019.09.017] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 35.0] [Reference Citation Analysis]
20 Lankadasari MB, Mukhopadhyay P, Mohammed S, Harikumar KB. TAMing pancreatic cancer: combat with a double edged sword. Mol Cancer 2019;18:48. [PMID: 30925924 DOI: 10.1186/s12943-019-0966-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 12.5] [Reference Citation Analysis]
21 Adamska A, Domenichini A, Falasca M. Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies. Int J Mol Sci. 2017;18. [PMID: 28640192 DOI: 10.3390/ijms18071338] [Cited by in Crossref: 210] [Cited by in F6Publishing: 198] [Article Influence: 52.5] [Reference Citation Analysis]
22 Kim JH, Youn Y, Kim KT, Jang G, Hwang JH. Non-SMC condensin I complex subunit H mediates mature chromosome condensation and DNA damage in pancreatic cancer cells. Sci Rep 2019;9:17889. [PMID: 31784646 DOI: 10.1038/s41598-019-54478-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Adamska A, Elaskalani O, Emmanouilidi A, Kim M, Abdol Razak NB, Metharom P, Falasca M. Molecular and cellular mechanisms of chemoresistance in pancreatic cancer. Adv Biol Regul 2018;68:77-87. [PMID: 29221990 DOI: 10.1016/j.jbior.2017.11.007] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 14.8] [Reference Citation Analysis]
24 Meng Q, Xu J, Liang C, Liu J, Hua J, Zhang Y, Ni Q, Shi S, Yu X. GPx1 is involved in the induction of protective autophagy in pancreatic cancer cells in response to glucose deprivation. Cell Death Dis 2018;9:1187. [PMID: 30538220 DOI: 10.1038/s41419-018-1244-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
25 Sim JJ, Jeong KY. Monitoring Epithelial-Mesenchymal Transition of Pancreatic Cancer Cells via Investigation of Mitochondrial Dysfunction. Methods Protoc 2020;3:E32. [PMID: 32349411 DOI: 10.3390/mps3020032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Mouhid L, Gómez de Cedrón M, García-Carrascosa E, Reglero G, Fornari T, Ramírez de Molina A. Yarrow supercritical extract exerts antitumoral properties by targeting lipid metabolism in pancreatic cancer. PLoS One 2019;14:e0214294. [PMID: 30913248 DOI: 10.1371/journal.pone.0214294] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
27 Du Y, Shang BY, Sheng WJ, Zhang SH, Li Y, Miao QF, Zhen YS. A recombinantly tailored β-defensin that displays intensive macropinocytosis-mediated uptake exerting potent efficacy against K-Ras mutant pancreatic cancer. Oncotarget 2016;7:58418-34. [PMID: 27517152 DOI: 10.18632/oncotarget.11170] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
28 Rawat M, Kadian K, Gupta Y, Kumar A, Chain PSG, Kovbasnjuk O, Kumar S, Parasher G. MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential. Genes (Basel) 2019;10:E752. [PMID: 31557962 DOI: 10.3390/genes10100752] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 13.5] [Reference Citation Analysis]
29 Yan Y, Fu G, Ming L. Role of exosomes in pancreatic cancer. Oncol Lett 2018;15:7479-88. [PMID: 29731898 DOI: 10.3892/ol.2018.8348] [Cited by in Crossref: 7] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
30 Xu YF, Hannafon BN, Zhao YD, Postier RG, Ding WQ. Plasma exosome miR-196a and miR-1246 are potential indicators of localized pancreatic cancer. Oncotarget. 2017;8:77028-77040. [PMID: 29100367 DOI: 10.18632/oncotarget.20332] [Cited by in Crossref: 66] [Cited by in F6Publishing: 73] [Article Influence: 16.5] [Reference Citation Analysis]
31 Domenichini A, Adamska A, Falasca M. ABC transporters as cancer drivers: Potential functions in cancer development. Biochim Biophys Acta Gen Subj 2019;1863:52-60. [PMID: 30268729 DOI: 10.1016/j.bbagen.2018.09.019] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 17.3] [Reference Citation Analysis]
32 Eissa IR, Bustos-Villalobos I, Ichinose T, Matsumura S, Naoe Y, Miyajima N, Morimoto D, Mukoyama N, Zhiwen W, Tanaka M, Hasegawa H, Sumigama S, Aleksic B, Kodera Y, Kasuya H. The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers. Cancers (Basel) 2018;10:E356. [PMID: 30261620 DOI: 10.3390/cancers10100356] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 22.0] [Reference Citation Analysis]
33 Liu M, Hancock SE, Sultani G, Wilkins BP, Ding E, Osborne B, Quek LE, Turner N. Snail-Overexpression Induces Epithelial-mesenchymal Transition and Metabolic Reprogramming in Human Pancreatic Ductal Adenocarcinoma and Non-tumorigenic Ductal Cells. J Clin Med 2019;8:E822. [PMID: 31181802 DOI: 10.3390/jcm8060822] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
34 Tjomsland V, Pomianowska E, Aasrum M, Sandnes D, Verbeke CS, Gladhaug IP. Profile of MMP and TIMP Expression in Human Pancreatic Stellate Cells: Regulation by IL-1α and TGFβ and Implications for Migration of Pancreatic Cancer Cells. Neoplasia 2016;18:447-56. [PMID: 27435927 DOI: 10.1016/j.neo.2016.06.003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
35 Adamska A, Domenichini A, Capone E, Damiani V, Akkaya BG, Linton KJ, Di Sebastiano P, Chen X, Keeton AB, Ramirez-Alcantara V, Maxuitenko Y, Piazza GA, De Laurenzi V, Sala G, Falasca M. Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer. J Exp Clin Cancer Res 2019;38:312. [PMID: 31378204 DOI: 10.1186/s13046-019-1308-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
36 Tone K, Ohno S, Honda M, Notsu A, Sasaki K, Sugino T. Application of enhancer of zeste homolog 2 immunocytochemistry to bile cytology. Cancer Cytopathol 2021;129:612-21. [PMID: 33788988 DOI: 10.1002/cncy.22426] [Reference Citation Analysis]
37 Durand N, Storz P. Targeting reactive oxygen species in development and progression of pancreatic cancer. Expert Rev Anticancer Ther 2017;17:19-31. [PMID: 27841037 DOI: 10.1080/14737140.2017.1261017] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
38 Chiellini F, Puppi D, Piras AM, Morelli A, Bartoli C, Migone C. Modelling of pancreatic ductal adenocarcinoma in vitro with three-dimensional microstructured hydrogels. RSC Adv 2016;6:54226-35. [DOI: 10.1039/c6ra08420f] [Cited by in Crossref: 19] [Article Influence: 3.8] [Reference Citation Analysis]
39 Kuang Y, Sechi M, Nurra S, Ljungman M, Neamati N. Design and Synthesis of Novel Reactive Oxygen Species Inducers for the Treatment of Pancreatic Ductal Adenocarcinoma. J Med Chem 2018;61:1576-94. [PMID: 29328656 DOI: 10.1021/acs.jmedchem.7b01463] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
40 Tahkola K, Leppänen J, Ahtiainen M, Väyrynen J, Haapasaari KM, Karttunen T, Kellokumpu I, Helminen O, Böhm J. Immune cell score in pancreatic cancer-comparison of hotspot and whole-section techniques. Virchows Arch 2019;474:691-9. [PMID: 30843106 DOI: 10.1007/s00428-019-02549-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
41 Pramanik KC, Makena MR, Bhowmick K, Pandey MK. Advancement of NF-κB Signaling Pathway: A Novel Target in Pancreatic Cancer. Int J Mol Sci 2018;19:E3890. [PMID: 30563089 DOI: 10.3390/ijms19123890] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 14.7] [Reference Citation Analysis]
42 Emmanouilidi A, Fyffe CA, Ferro R, Edling CE, Capone E, Sestito S, Rapposelli S, Lattanzio R, Iacobelli S, Sala G, Maffucci T, Falasca M. Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer. J Exp Clin Cancer Res 2019;38:191. [PMID: 31088502 DOI: 10.1186/s13046-019-1191-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
43 van Straten D, Mashayekhi V, de Bruijn HS, Oliveira S, Robinson DJ. Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions. Cancers (Basel) 2017;9:E19. [PMID: 28218708 DOI: 10.3390/cancers9020019] [Cited by in Crossref: 355] [Cited by in F6Publishing: 299] [Article Influence: 88.8] [Reference Citation Analysis]
44 Elaskalani O, Falasca M, Moran N, Berndt MC, Metharom P. The Role of Platelet-Derived ADP and ATP in Promoting Pancreatic Cancer Cell Survival and Gemcitabine Resistance. Cancers (Basel). 2017;9. [PMID: 29064388 DOI: 10.3390/cancers9100142] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
45 Zhong A, Cheng CS, Kai J, Lu R, Guo L. Clinical Significance of Glucose to Lymphocyte Ratio (GLR) as a Prognostic Marker for Patients With Pancreatic Cancer. Front Oncol 2020;10:520330. [PMID: 33117673 DOI: 10.3389/fonc.2020.520330] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
46 Chen P, Shen Z, Fang X, Wang G, Wang X, Wang J, Xi S. Silencing of keratin 17 by lentivirus-mediated short hairpin RNA inhibits the proliferation of PANC-1 human pancreatic cancer cells. Oncol Lett 2020;19:3531-41. [PMID: 32269627 DOI: 10.3892/ol.2020.11469] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
47 Wang LH, Huang J, Wu CR, Huang LY, Cui J, Xing ZZ, Zhao CY. Downregulation of miR‑29b targets DNMT3b to suppress cellular apoptosis and enhance proliferation in pancreatic cancer. Mol Med Rep 2018;17:2113-20. [PMID: 29207141 DOI: 10.3892/mmr.2017.8145] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
48 Adamska A, Falasca M. ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward? World J Gastroenterol 2018; 24(29): 3222-3238 [PMID: 30090003 DOI: 10.3748/wjg.v24.i29.3222] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 38] [Article Influence: 12.7] [Reference Citation Analysis]
49 Emmanouilidi A, Paladin D, Greening DW, Falasca M. Oncogenic and Non‐Malignant Pancreatic Exosome Cargo Reveal Distinct Expression of Oncogenic and Prognostic Factors Involved in Tumor Invasion and Metastasis. Proteomics 2019;19:1800158. [DOI: 10.1002/pmic.201800158] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 11.0] [Reference Citation Analysis]